(PC) Thompson v. Bick

District Court, E.D. California·Decided August 10, 2022·No. 2:19-cv-01651·Unknown

Opinion

TYRONE THOMPSON, Case No. 2:19-cv-01651-JDP (PC) Plaintiff, ORDER GRANTING DEFENDANTS’ MOTION FOR SUMMARY JUDGMENT v. ECF No. 26 BICK, et al., Defendants. Plaintiff, a state prisoner proceeding without counsel in this action brought under 42 U.S.C. § 1983, alleges that defendants Petras and Bick violated his Eighth Amendment rights by terminating his methadone prescription. ECF No. 10. Defendants move for summary judgment, arguing that plaintiff cannot show that they were deliberately indifferent to his medical needs. ECF No. 26. The court grants summary judgment in defendants’ favor. Background Plaintiff has experienced chronic low back pain for more than two decades and has periodically been treated with opioid pain medications. See ECF No. 26-5 at 13. Following his 2014 transfer to California Medical Facility (“CMF”), a medical provider not named in this suit prescribed him methadone, which he claims both reduced his urinary and fecal incontinence and also reduced his pain to a level that allowed him to walk, attend classes, and perform daily activities. ECF No. 30 at 3. Plaintiff attests that, in October 2018, his primary care provider—then Dr. Ota—explained that because of guidelines promulgated by defendant Bick, CMF’s Chief Medical Officer, she had been instructed “to taper [plaintiff] off of [his] pain medication (methadone).” Id. at 4-5. Ota wrote in plaintiff’s medical record that she had decided to taper his methadone “because he [wa]s on an unsafe level [of] over 90 morphine milligram equivalents.” Id. at 240. She further explained that there was “a lack of evidence of long-term improvement in the amount of pain,” and that his methadone use “places him at a risk for physical and psychological dependence, drug overdose, and death.” Id. In a November 2018 response to a health care grievance, defendant Bick stated that “[t]he department is reviewing all patients across the state to ensure that the benefits of opiates outweighs the risk.” Id. at 72. On December 18, 2018, plaintiff signed a form titled “Informed Consent for Treatment with Opioid Medication,” noting his acknowledgement of the major health risks associated with opioid medications, including overdose and dependence, and consenting to “strict rules for the use of opioid medications.” ECF No. 26-5 at 12. In February 2019, Ota informed plaintiff that Petras would be taking over as his primary care provider and on March 4, 2019, Petras had his first visit with plaintiff in this role. ECF No. 30 at 10-11, 246. According to his progress notes from that visit, plaintiff had been tapered to a daily dose of approximately 45 morphine milligram equivalents of methadone and placed on a trial of gabapentin. Id. at 246. He reported to Petras that both his pain and mobility had worsened since beginning to taper off of methadone. Id. He attests that Petras nevertheless told him that he would be tapered entirely off methadone pursuant to defendant Bick’s new guidelines. Id. at 10. Under a section of the March 4 progress note entitled “Assessment/Plan,” Petras wrote that he discussed with plaintiff “the utility of tapering him off opioids entirely . . . [and] explained to him that [an] MRI from 2016 did not explain the severity of his pain or disability.” ECF No. 26-5 at 25. Additional notes from that visit state that the MRI showed only “mild degenerative changes, nothing that would cause him to be [wheelchair] bound most of the time or [to] have severe debilitating lumbar spinal stenosis symptoms”; that plaintiff “will be referred to [physical therapy] for remobilization”; and, that an “interventional pain specialist is needed once opioids have been washed out completely.” Id.1 Plaintiff saw Petras again on March 29, 2019, id. at 21, at which visit he reported, “I am in serious pain, urinating and defecating on myself a lot, I can hardly walk or stand, I am having problems with going to get my insulin that I really need,” id.; ECF No. 30 at 11. At that visit, Petras asked him to provide a urine sample to test whether he had been taking his methadone as prescribed. Id. Petras wrote, “I have reconsidered stoppage of methadone at this moment due to legitimate functional complaints by the patient. [H]e is also on a much safer dosage than previously. [I]f [his urine toxicology screening] is normal I will request [an] eval[uation] by [CMF] pain[] [committee].” ECF No. 26-5 at 22. On April 11, 2019, plaintiff received a note from Petras regarding his urine toxicology screening: Dear Mr. Thompson, your recent urine toxicology screen is negative for any substances including the methadone you have been prescribed. It is reasonable to conclude you are diverting all your prescribed methadone or that you substituted water or someone else’s urine for the urine sample you submitted. In either case, I am required to taper and stop your methadone under these circumstances. Id. at 10. In his declaration, Petras attests that “terminating plaintiff’s methadone prescription following a urine toxicology drug screen with a negative result for methadone was not only appropriate[] but was required and medically necessary.” Id. at 2. He also attests that “[u]pon review of [plaintiff’s] medical records, including the result of an MRI, there did not appear to be an objective medical reason for the level of pain and level of disability of plaintiff.” Id. For at least a year following the discontinuation of his methadone, plaintiff complained of pain in his back, decreased mobility, worsening sleep, and a lack of control over urination and defecation, without receiving methadone or other opioid pain medications. Id. at 12-17. His 1 Plaintiff also claims that around this time he requested pain medication to treat his diabetic foot pain, although he does not appear to base his deliberate indifference claim on these facts. See ECF No. 30 at 8 & 25. He appears to claim that Ota requested approval from Bick to prescribe gabapentin for his diabetic foot pain. Id. at 8. Although he does not state whether he received gabapentin, Petras wrote in the progress notes from the March 4 visit that he was “stopp[ing] gabapentin” after a one-month trial because plaintiff had stated that it “did nothing for his pain.” Id. at 246. medical records show that Petras conducted additional X-ray and MRI examinations of his lumbar spine in April and June 2019, and that he provided alternative pain medications, such as acetaminophen and topical cream. Id. at 16. Plaintiff maintains that these treatments were ineffective and that the deprivation of methadone constituted deliberate indifference to his serious medical needs. Legal Standards A. Summary Judgment Standard Summary judgment is appropriate where there is “no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a); Washington Mutual Inc. v. United States, 636 F.3d 1207, 1216 (9th Cir. 2011). An issue of fact is genuine only if there is sufficient evidence for a reasonable factfinder to find for the non-moving party, while a fact is material if it “might affect the outcome of the suit under the governing law.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986); Wool v. Tandem Computers, Inc., 818 F.2d 1422, 1436 (9th Cir. 1987). Each party’s position must be supported by (1) citations to particular portions of materials in the record, including but not limited to portions of depositions, documents, declarations, or discovery; or (2) argument showing that the materials cited do not establish the presence or absence of a genuine factual dispute or that the opposing party cannot produce admissible evidence to support its position. See Fed. R. C

Free access — add to your briefcase to read the full text and ask questions with AI

(PC) Thompson v. Bick, (E.D. Cal. 2022).

(PC) Thompson v. Bick ((PC) Thompson v. Bick) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Dodds v. Richardson
614 F.3d 1185 (Tenth Circuit, 2010)
John C. McGuckin v. Dr. Smith John C. Medlen, Dr.
974 F.2d 1050 (Ninth Circuit, 1992)
Robin Orr v. Bank of America, Nt & Sa
285 F.3d 764 (Ninth Circuit, 2002)
Gibson v. County of Washoe, Nevada
290 F.3d 1175 (Ninth Circuit, 2002)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Wilhelm v. Rotman
680 F.3d 1113 (Ninth Circuit, 2012)
Osu Student Alliance v. Ed Ray
699 F.3d 1053 (Ninth Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
United States v. Darnell Mitchell
743 F.3d 1054 (Sixth Circuit, 2014)